{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:14:15Z","timestamp":1793258055013,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["201807019A"],"award-info":[{"award-number":["201807019A"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["201807019A"],"award-info":[{"award-number":["201807019A"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Screening of pregnant women carrying human T-lymphotropic virus type 1 (HTLV-1) has a crucial role in reducing the number of HTLV-1 carriers. A national HTLV-1 screening program for pregnant women was started in 2011 in Japan. The purpose of this study is to report on the implementation of this nationwide screening program.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a retrospective repeated cross-sectional study. We used datasets from surveys of HTLV-1-antibody-positive pregnant women performed by the Japan Association of Obstetricians and Gynecologists in 2011, 2013, and 2016. Outcomes for evaluation included the number of persons (pregnant women) who conducted the screening test, the number of positive persons (women) identified by these tests, and the proportion of positive persons to the number of persons (women) who conducted the tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Numbers of target facilities changed yearly: 1857 in 2011, 2544 in 2013, and 2376 in 2016. The mean number of screening-test participants increased per facility, but the median increased or decreased. The mean number of positive individuals identified decreased. Multivariate analysis results revealed the number of screenings was slightly reduced yearly, although areas (Kanto and Kinki) and high volume in facility types increased. Regarding the positive rates, some areas (Hokkaido\/Tohoku, Kanto, and Chugoku\/Shikoku) exhibited decreases or increases by facility type. The number of western blotting (WB) implementations decreased in 2016, positive rates identified by WB decreased in 2016 in all areas, and the number of facility types increased. The number of PCR participants increased in 2016 in Kanto and Kinki, but a decrease in facility type was observed. Positive rates were decreased in all areas (except the central region) but facility types were increased.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The nationwide screening program for HTLV-1 in Japan was almost fully implemented. However, regional variations in screening tests were observed during this implementation. Thus, some incentives are needed to encourage proper implementation across all regions.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12889-020-09258-4","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T11:04:14Z","timestamp":1595415854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Implementation of nationwide screening of pregnant women for HTLV-1 infection in Japan: analysis of a repeated cross-sectional study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3637-2095","authenticated-orcid":false,"given":"Naohiro","family":"Yonemoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Sekizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Itabashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"9258_CR1","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/infdis\/jiy017","volume":"217","author":"N Fuchi","year":"2018","unstructured":"Fuchi N, Miura K, Tsukiyama T, Sasaki D, Ishihara K, Tsuruda K, Hasegawa H, Miura S, Yanagihara K, Masuzaki H. Natural course of human T-cell leukemia virus type 1 Proviral DNA levels in carriers during pregnancy. J Infect Dis. 2018;217:1383\u20139.","journal-title":"J Infect Dis"},{"key":"9258_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/0140-6736(90)92896-P","volume":"336","author":"L LaGrenade","year":"1990","unstructured":"LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet. 1990;336:1345\u20137.","journal-title":"Lancet."},{"key":"9258_CR3","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/S0140-6736(18)30974-7","volume":"391","author":"F Martin","year":"2018","unstructured":"Martin F, Tagaya Y, Gallo R. Time to eradicate HTLV-1: an open letter to WHO. Lancet. 2018;391:1893\u20134.","journal-title":"Lancet."},{"key":"9258_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.antiviral.2016.10.015","volume":"137","author":"L Willems","year":"2017","unstructured":"Willems L, Hasegawa H, Accolla R, Bangham C, Bazarbachi A, Bertazzoni U, Carneiro-Proietti AB, Cheng H, Chieco-Bianchi L, Ciminale V, Coelho-Dos-Reis J, Esparza J, Gallo RC, Gessain A, Gotuzzo E, Hall W, Harford J, Hermine O, Jacobson S, Macchi B, Macpherson C, Mahieux R, Matsuoka M, Murphy E, Peloponese JM, Simon V, Tagaya Y, Taylor GP, Watanabe T, Yamano Y. Reducing the global burden of HTLV-1 infection: an agenda for research and action. Antivir Res. 2017;137:41\u20138.","journal-title":"Antivir Res"},{"key":"9258_CR5","first-page":"174","volume":"17","author":"R Boostani","year":"2018","unstructured":"Boostani R, Sadeghi R, Sabouri A, Ghabeli-Juibary A. Human T-lymphotropic virus type I and breastfeeding; systematic review and meta-analysis of the literature. Iran J Neurol. 2018;17:174\u20139.","journal-title":"Iran J Neurol"},{"key":"9258_CR6","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.3390\/v8020040","volume":"8","author":"F Percher","year":"2016","unstructured":"Percher F, Jeannin P, Martin-Latil S, Gessain A, Afonso PV, Vidy-Roche A, Ceccaldi PE. Mother-to-Child Transmission of HTLV-1 Epidemiological Aspects, Mechanisms and Determinants of Mother-to-Child Transmission. Viruses. 2016;8:E40.","journal-title":"Viruses"},{"key":"9258_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/INF.0b013e31827efc39","volume":"32","author":"H Moriuchi","year":"2013","unstructured":"Moriuchi H, Masuzaki H, Doi H, Katamine S. Mother to-child transmission of human T-cell lymphotropic virus type1. Pediatr Infect Dis J. 2013;32:175\u20137.","journal-title":"Pediatr Infect Dis J"},{"key":"9258_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3389\/fmicb.2019.00999","volume":"10","author":"C Rosadas","year":"2019","unstructured":"Rosadas C, Taylor GP. Mother-to-Child HTLV-1 Transmission: Unmet Research Needs. Front Microbiol. 2019;10:999.","journal-title":"Front Microbiol"},{"key":"9258_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1542\/peds.86.1.11","volume":"86","author":"Y Tsuji","year":"1990","unstructured":"Tsuji Y, Doi H, Yamabe T, Ishimaru T, Miyamoto T, Hino S. Prevention of mother-to-child transmission of human T-lymphotropic virus type-I. Pediatrics. 1990;86:11\u20137.","journal-title":"Pediatrics"},{"key":"9258_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jcv.2009.03.012","volume":"45","author":"N Eshima","year":"2009","unstructured":"Eshima N, Iwata O, Iwata S, Tabata M, Higuchi Y, Matsuishi T, Karukaya S. Age and gender specific prevalence of HTLV-1. J Clin Virol. 2009;45:135\u20138.","journal-title":"J Clin Virol"},{"key":"9258_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/1348-0421.12165","volume":"58","author":"T Yamada","year":"2014","unstructured":"Yamada T, Togashi T, Tsutsumi H, Imamura M, Okubo H, Okabe M, Takamuro N, Tashiro K, Yano K, Yamamoto N, Hirakawa Y, Minakami H. Prevalence of human T-lymphotropic virus type 1 carriers among pregnant women in Hokkaido, Japan. Microbiol Immunol. 2014;58:427\u201331.","journal-title":"Microbiol Immunol"},{"key":"9258_CR12","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/S1473-3099(16)30252-3","volume":"16","author":"M Satake","year":"2016","unstructured":"Satake M, Iwanaga M, Sagara Y, Watanabe T, Okuma K, Hamaguchi I. Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis. Lancet Infect Dis. 2016;16:1246\u201354.","journal-title":"Lancet Infect Dis"},{"key":"9258_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jmv.23181","volume":"84","author":"M Satake","year":"2012","unstructured":"Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84:327\u201335.","journal-title":"J Med Virol"},{"key":"9258_CR14","doi-asserted-by":"crossref","unstructured":"Minakami H, Hiramatsu Y, Koresawa M, Fujii T, Hamada H, Iitsuka Y, Ikeda T, Ishikawa H, Ishimoto H, Itoh H, Kanayama N, Kasuga Y, Kawabata M, Konishi I, Matsubara S, Matsuda H, Murakoshi T, Ohkuchi A, Okai T, Saito S, Sakai M, Satoh S, Sekizawa A, Suzuki M, Takahashi T, Tokunaga A, Tsukahara Y, Yoshikawa H. Japan Society of Obstetrics and Gynecology, Japan Association of Obstetricians and Gynecologists, (2011) Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2011 edition. J Obstet Gynaecol Res. 37:1174\u201397.","DOI":"10.1111\/j.1447-0756.2011.01653.x"},{"key":"9258_CR15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fmicb.2020.00595","volume":"11","author":"K Itabashi","year":"2020","unstructured":"Itabashi K, Miyazawa T, Sekizawa A, Tokita A, Saito S, Moriuchi H, Nerome Y, Uchimaru K, Watanabe T. A Nationwide antenatal human T-cell leukemia virus Type-1 antibody Screening in Japan. Front Microbiol. 2020;11:595.","journal-title":"Front Microbiol"},{"key":"9258_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.14740\/jocmr2097w","volume":"7","author":"S Suzuki","year":"2015","unstructured":"Suzuki S, Tanaka M, Matsuda H, Tsukahara Y, Kuribayashi Y, Nakai A, Miyazaki T, Kamiya N, Sekizawa A, Mizutani N, Kinoshita K. Prevalence of human T-cell leukemia virus type 1 carrier in Japanese pregnant women in 2013. J Clin Med Res. 2015;7:499\u2013500.","journal-title":"J Clin Med Res"},{"key":"9258_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3109\/14767058.2013.814631","volume":"27","author":"S Suzuki","year":"2014","unstructured":"Suzuki S, Tanaka M, Matsuda H, Tsukahara Y, Kuribayashi Y, Gomibuchi H, Miyazaki R, Kamiya N, Nakai A. Kinoshita K; Japan Association of Obstetricians and Gynecologists. Current status of HTLV-1 carrier in Japanese pregnant women. J Matern Fetal Neonatal Med. 2014;27:312\u20133.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"9258_CR18","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3109\/14767058.2013.852175","volume":"27","author":"S Suzuki","year":"2014","unstructured":"Suzuki S, Tanaka M, Matsuda H, Tsukahara Y, Kuribayashi Y, Gomibuchi H, Miyazaki R, Kamiya N, Nakai A, Kinoshita K. Instruction of feeding methods to Japanese pregnant women who cannot be confirmed as HTLV-1 carrier by western blot test. J Matern Fetal Neonatal Med. 2014;27:1392\u20133.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"9258_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC. Vandenbroucke JP; STROBE initiative. Strengthening the reporting of observational studies in epidemiology (STROBE)statement: guidelines for reporting observational studies. BMJ. 2007;335:806\u20138.","journal-title":"BMJ."},{"key":"9258_CR20","unstructured":"Ministry of Health, Labour and Welfare, Vital statistics in Japan https:\/\/www.mhlw.go.jp\/english\/database\/db-hw\/vs01.html."},{"key":"9258_CR21","doi-asserted-by":"crossref","unstructured":"Shoukri MM, Chaudhary MA. Analysis of correlated data with SAS and R. 3rd ed: Chapman & Hall\/CRC, Taylor & Francis group; 2007.","DOI":"10.1201\/b15949"},{"key":"9258_CR22","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/INF.0b013e318263215e","volume":"31","author":"MA Ribeiro","year":"2012","unstructured":"Ribeiro MA, Martins ML, Teixeira C, Ladeira R, Oliveira Mde F, Janu\u00e1rio JN, Proietti FA, Carneiro-Proietti AB. Blocking vertical transmission of human T cell lymphotropic virus type 1 and 2 through breastfeeding interruption. Pediatr Infect Dis J. 2012;31:1139\u201343.","journal-title":"Pediatr Infect Dis J"},{"key":"9258_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006913","volume":"12","author":"C Rosadas","year":"2018","unstructured":"Rosadas C, Malik B, Taylor GP, Puccioni-Sohler M. Estimation of HTLV-1 vertical transmission cases in Brazil per annum. PLoS Negl Trop Dis. 2018;12:e0006913.","journal-title":"PLoS Negl Trop Dis"},{"key":"9258_CR24","unstructured":"UK National Screening Committee. Antenatal Screening for HTLV infection. Available online at: https:\/\/legacyscreening.phe.org.uk\/policydb_download.php?doc=704 (accessed June 13, 2020)."},{"key":"9258_CR25","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/bjh.15234","volume":"184","author":"B Malik","year":"2019","unstructured":"Malik B, Taylor GP. Can we reduce the incidence of adult T-cell leukaemia\/ lymphoma? Cost-effectiveness of human T-lymphotropic virus type 1 (HTLV-1) antenatal screening in the United Kingdom. Br J Haematol. 2019;184:1040\u20133.","journal-title":"Br J Haematol"}],"updated-by":[{"DOI":"10.1186\/s12889-020-09314-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000}},{"DOI":"10.1186\/s12889-021-11049-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000}}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09258-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-020-09258-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09258-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T23:12:27Z","timestamp":1667517147000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-09258-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9258"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-09258-4","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12889-021-11049-4","asserted-by":"object"},{"id-type":"doi","id":"10.1186\/s12889-020-09314-z","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"25 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12889-020-09314-z","URL":"https:\/\/doi.org\/10.1186\/s12889-020-09314-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12889-021-11049-4","URL":"https:\/\/doi.org\/10.1186\/s12889-021-11049-4","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of the Japan Association of Obstetricians and Gynecologists. The survey was institutional and contained no individual information (pregnant women or children).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NY is a member of Editorial Board. SS, AS, SH, YS, and KI declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1150"}}